Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Universiteitsweg 99,, 3584, CG Utrecht, The Netherlands.
Department of Orthopaedics, University Medical Center Utrecht, Utrecht University, P.O. Box 85500,, 3508, GA Utrecht, The Netherlands.
Macromol Biosci. 2019 Feb;19(2):e1800412. doi: 10.1002/mabi.201800412. Epub 2018 Dec 13.
The increasing prevalence of end-stage renal disease and persistent shortage of donor organs call for alternative therapies for kidney patients. Dialysis remains an inferior treatment as clearance of large and protein-bound waste products depends on active tubular secretion. Biofabricated tissues could make a valuable contribution, but kidneys are highly intricate and multifunctional organs. Depending on the therapeutic objective, suitable cell sources and scaffolds must be selected. This study provides a proof-of-concept for stand-alone kidney tubule grafts with suitable mechanical properties for future implantation purposes. Porous tubular nanofiber scaffolds are fabricated by electrospinning 12%, 16%, and 20% poly-ε-caprolactone (PCL) v/w (chloroform and dimethylformamide, 1:3) around 0.7 mm needle templates. The resulting scaffolds consist of 92%, 69%, and 54% nanofibers compared to microfibers, respectively. After biofunctionalization with L-3,4-dihydroxyphenylalanine and collagen IV, 10 × 10 proximal tubule cells per mL are injected and cultured until experimental readout. A human-derived cell model can bridge all fiber-to-fiber distances to form a monolayer, whereas small-sized murine cells form monolayers on dense nanofiber meshes only. Fabricated constructs remain viable for at least 3 weeks and maintain functionality as shown by inhibitor-sensitive transport activity, which suggests clearance capacity for both negatively and positively charged solutes.
终末期肾病的发病率不断上升,而捐赠器官持续短缺,这使得肾脏患者需要替代疗法。透析仍然是一种较差的治疗方法,因为清除大分子量和蛋白结合型废物依赖于活跃的管状分泌。生物制造的组织可以做出有价值的贡献,但肾脏是高度复杂和多功能的器官。根据治疗目标,必须选择合适的细胞来源和支架。本研究为具有适合未来植入目的的独立肾小管移植物提供了概念验证。通过静电纺丝,在 0.7 毫米的针模板周围分别制备了 12%、16%和 20%的聚己内酯(PCL)/w(氯仿和二甲基甲酰胺,1:3)的多孔管状纳米纤维支架。与微纤维相比,所得支架分别由 92%、69%和 54%的纳米纤维组成。经过 L-3,4-二羟基苯丙氨酸和胶原蛋白 IV 的生物功能化后,每毫升注射并培养 10×10 个近端肾小管细胞,直到进行实验读数。人类来源的细胞模型可以桥接所有纤维到纤维的距离以形成单层,而小尺寸的鼠源细胞仅在密集的纳米纤维网格上形成单层。制造的构建体至少在 3 周内保持存活并保持功能,如抑制剂敏感的转运活性所示,这表明对带负电荷和带正电荷的溶质都具有清除能力。